References

Allyse, M., M.A. Minear, E. Berson, S. Sridhar and M. Rote et al., 2015. Non-invasive prenatal testing: A review of international implementation and challenges. Intl. J. Womens Health, 7: 113-126.
CrossRef  |  PubMed  |  Direct Link  |  

Bernasconi, A., 2018. Nondisjunction-the causes of nondisjunction and its frequency in humans. Net Industries Inc., Indianapolis, Indiana. http://medicine.jrank.org/pages/2605/Nondisjunction-Causes-Nondisjunction-Its-Frequency-in-Humans.html

Bucerzan, S., R.A. Popp, R.M. Vlad, C. Lazea and R. Nicolaescu et al., 2017. Evaluation of c677t and a1298c polymorphism of the methylenetetrahydrofolate reductase gene as a maternal risk factor for trisomy 21 (A Monocentric Study). Rom. J. Lab. Med., 25: 27-35.
CrossRef  |  Direct Link  |  

Christianson, R.E., S.L. Sherman and C.P. Torfs, 2004. Maternal meiosis II Nondisjunction in Trisomy 21 is associated with maternal low socioeconomic status. Genet. Med., 6: 487-494.
CrossRef  |  PubMed  |  Direct Link  |  

De Groot-Van Der Mooren, M.D., S. Tamminga, D. Oepkes, M.E. Weijerman and M.C. Martina, 2018. Older mothers and increased impact of prenatal screening: Stable livebirth prevalence of Trisomy 21 in the Netherlands for the period 2000-2013. Eur. J. Hum. Genet., 26: 157-165.
CrossRef  |  Direct Link  |  

Liao, Y.P.1, M.S. Bao, C.Q. Liu and H.Z.D. Liu, 2010. No title. Yi Chuan, 32: 461-466.

Norton, M.E., L.L. Jelliffe-Pawlowski and R.J. Currier, 2014. Chromosome abnormalities detected by current prenatal screening and noninvasive prenatal testing. Obstetrics Gynecology, 124: 979-986.
CrossRef  |  PubMed  |  Direct Link  |  

Parker, S.E., C.T. Mai, M.A. Canfield, R. Rickard and Y. Wang et al., 2010. Updated national birth prevalence estimates for selected birth defects in the United States, 2004-2006. Birth Defects Res., 88: 1008-1016.
CrossRef  |  Direct Link  |  

Patterson, D., 2008. Folate metabolism and the risk of down syndrome. Down Syndrome Res. Pract., 12: 93-97.
CrossRef  |  PubMed  |  Direct Link  |  

Rai, V. and P. Kumar, 2018. Fetal MTHFR C677T polymorphism confers no susceptibility to Down syndrome: Evidence from meta-analysis. Egyptian J. Med. Hum. Genet., 19: 53-58.
CrossRef  |  Direct Link  |  

Rochmah, Y.S., L. Suwarsi, S. Harumsari, A. Sosiawan and S. Fatimah-Muis et al., 2018. Maternal polymorphism MTHFR A1298C not C677T and MSX1 as the risk factors of non-syndrome cleft Lips/Palate in Sasak Tribe Indonesia. J. Intl. Dental Med. Res., 11: 120-123.
Direct Link  |  

Scala, I., B. Granese, M. Sellitto, S. Salome and A. Sammartino et al., 2006. Analysis of seven maternal polymorphisms of genes involved in homocysteine/folate metabolism and risk of Down syndrome offspring. Genet. Med., 8: 409-416.
PubMed  |  

Shalaby, H.M.A., 2011. A study of new potential risk factors for Down syndrome in Upper Egypt. Egypt. J. Med. Hum. Genet., 12: 15-19.
CrossRef  |  Direct Link  |  

Vogel, I. and O.B. Petersen, 2018. Prenatal screening for atypical chromosomal abnormalities: Past or future?. Ultrasound Obstetrics Gynecology, 51: 434-435.
CrossRef  |  Direct Link  |